# Starting Granulocyte Colony-Stimulating Factor at 1 Day vs 3 Days Following Chemotherapy in Pediatric Cancer Patients

> **NCT03823950** · PHASE4 · UNKNOWN · sponsor: **University of Mississippi Medical Center** · enrollment: 150 (estimated)

## Conditions studied

- Granulocyte Colony-Stimulating Factor
- Chemotherapy-induced Neutropenia
- Chemotherapy-Induced Febrile Neutropenia
- Pediatric Cancer

## Interventions

- **DRUG:** Granulocyte Colony-Stimulating Factor

## Key facts

- **NCT ID:** NCT03823950
- **Lead sponsor:** University of Mississippi Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-02-01
- **Primary completion:** 2021-12
- **Final completion:** 2022-06
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2020-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03823950

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03823950, "Starting Granulocyte Colony-Stimulating Factor at 1 Day vs 3 Days Following Chemotherapy in Pediatric Cancer Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03823950. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*